In conclusion, our study sheds light on the novel therapeutic potential of Sirt6-enriched exosomes derived from adipose stem cells (ASCs) against myocardial ischemia/reperfusion injury (MIRI). This evidence concerns the gene SIRT6 and myocardial ischemia.